HOME | LOGIN | JOIN US  
APJCP APJCP Submission APOCP APOCP Documents  
Search 
 
   
About the APJCP 
 Information for Authors
 APJCP Issues 
VOLUME 15, 2014  Issue Number 19 , 8127-8134
DownLoad : 8127-8134 4.15 Siew Yim Loh.pdf
RESEARCH ARTICLE
The Kuala Lumpur Qigong Trial for Women in the Cancer Survivorship Phase-Efficacy of a Three-Arm RCT to Improve QOL
Siew Yim Loh et al
Abstract
Background: Qigong is highly favoured among Asian breast cancer survivors for enhancing health. This
study examined the hypothesis that quality of life (QoL) in the Qigong group is better than the placebo (aerobic)
or usual care group. Materials and Methods: A total of 197 participants were randomly assigned to either the
8-week Kuala Lumpur Qigong Trial or control groups in 2010-2011. Measurement taken at baseline and postintervention
included QoL, distress and fatigue. Analysis of covariance (ANCOVA) and Kruskal Wallis were used
to examine for differences between groups in the measurements. Results: There were 95 consenting participants
in this 8week trial. The adherence rates were 63% for Qigong and 65% for the placebo group. The Qigong group
showed significant marginal improvement in Quality of life scores compared to placebo (mean difference=7.3
unit; p=0.036), compared to usual care (mean difference=6.7 unit; p=0.048) on Functional Assessment Cancer
Therapy-Breast measure. There were no significant changes between the placebo and usual care groups in
fatigue or distress at post intervention (8-week). Conclusions: Cancer survivors who participated in the Qigong
intervention showed slightly better QOL. Follow up studies are greatly needed to evaluate which subgroups may
best benefit from Qigong. With a steep rise of cancer survivors, there is an urgent need to explore and engage
more cultural means of physical activity to fight side effects of treatment and for cancer control in developing
countries.
Key Words: Qigong - quality of life - cancer prevention - cancer survivors - lifestyle
 
APJCP Editorial Office : National Cancer Center, Korea. Tel : +82-31-920-1914 Fax : +82-31-920-1939
E-mail : [email protected]
323 Ilsan-ro, Ilsandong-gu, Goyang-si Gyeonggi-do, 410-769, Republic of Korea
Copyright ⓒ National Cancer Center, Korea. All Rights Reserved.